Search
for
Sort by
Research 811–840 of 1000+
- Effects of Androgen Treatment on Growth in Patients with 5-α-Reductase Type 2 Deficiency
- Hormone therapy for transgender patients
- Polycystic Ovary Syndrome: Diagnosis and Treatment
- Topical ketoconazole: a systematic review of current dermatological applications and future developments
- Polycystic ovary syndrome is associated with anogenital distance, a marker of prenatal androgen exposure
- Hormonal Parameters in Androgenetic Hair Loss in the Male
- Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome
- Exclusive androgenic effect of dehydroepiandrosterone in sebaceous glands of rat skin
- Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials
- Guava (Psidium guajava L.) Leaf Extract as Bioactive Substances for Anti-Androgen and Antioxidant Activities
- Hair and scalp disorders
- Pharmacological Treatment of Alopecia
- Acupuncture in Polycystic Ovary Syndrome: Potential and Challenge
- Polycystic Ovary Syndrome: A Complex Interplay of Hormones and Metabolism
- current possible treatment approaches of Polycystic Ovary Syndrome (PCOS)
- Comparison of Clinical and Biochemical Markers of Hirsutism in Polycystic Ovary Syndrome – A Study from a Teaching Hospital in Sri Ramachandra Institute, Chennai, India
- Comparison of Components of Metabolic Syndrome in Androgenic Alopecia versus Healthy Population
- Polycystic Ovary Syndrome: Conditions, Genetics and Current Cure
- Polycystic Ovary Syndrome
- Prevalence of androgenic alopecia (AGA) in patients with polycystic ovarian syndrome (PCOS) and characterization of associated clinical and biochemical features
- Recommendations of endocrine treatment for patients with gender dysphoria
- The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial
- Polycystic ovary syndrome and the risk of obstructive sleep apnea: a meta-analysis and review of the literature
- Anti‐androgens may protect against severe COVID‐19 outcomes: results from a prospective cohort study of 77 hospitalized men
- Evidence-based approach to cutaneous hyperandrogenism in women
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Structure of human steroid 5α-reductase 2 with the anti-androgen drug finasteride
- A variant of the glucocorticoid receptor gene is not associated with adrenal androgen excess in women with polycystic ovary syndrome
- Selective androgen receptor modulators (SARMs) have specific impacts on the mouse uterus
- Synthesis of 11α-hydroxyprogesterone hartens